About Diabetic Macular Edema or Diabetic Retinopathy in DME About Diabetic Macular Edema or Diabetic Retinopathy in DME

Under-standing DME/DR in DME

What are Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR), and what can they do to your eyes?

Picture of effects of DME/DR in DME on the eye, showing small areas of bleeding, macular edema, macula, retina, and microaneurysms.

WHO DOES DME/DR IN DME AFFECT?

Diabetes is the leading cause of new cases of blindness in people 20 to 74 years of age in the United States. DR is the most common eye problem caused by diabetes, and DME is a complication of DR which is a serious condition that can cause vision problems.

HOW CAN DME/DR IN DME AFFECT MY EYES?

DR happens when too much blood sugar (glucose) damages the blood vessels in the retina. As a result:

  • The retina does not get enough blood and nutrients
  • Blood vessels can leak blood into the retina

DME is a complication of DR. In DME, the macula swells with fluid leaked from the damaged blood vessels.

If you're living with diabetes, be sure to get a dilated eye exam at least once a year.

DIABETES CAN PERMANENTLY AFFECT YOUR VISION

If you have diabetes, a dilated eye exam can detect changes in your vision. Don't wait. Be sure to get a dilated eye exam at least once a year. Also be sure to follow up with your eye doctor on a regular basis.

FIND OUT MORE ABOUT DME/DR IN DME

Meet Lea and learn more about how DME/DR in DME may affect your eyesight.

View study results for EYLEA, an anti-VEGF treatment for patients with DME/DR in DME.

SEE THE RESULTS OF EYLEA

EYLEA has been studied in more than 3,000 people with certain diseases of the retina. Learn more about the #1 prescribed FDA-approved anti-vascular endothelial growth factor treatment for patients with DME/DR in DME.

EYLEA is a prescription medicine given by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.

Learn how EYLEA may be able to help

SIGN UP FOR MORE INFORMATION

TIPS FOR LIVING WITH LOW VISION

THE SYMPTOMS OF DME THROUGH VIRTUAL REALITY

Get the latest materials and communications about EYLEA—and a complimentary pocket magnifier, too.

Just a few changes may make a big difference in your daily routine.

See the common symptoms of DME/DR in DME with the mobile app, In My Eyes. You can also share the app with your loved ones to help them better understand what you may be experiencing.

IMPORTANT SAFETY INFORMATION
  • EYLEA® (aflibercept) Injection is a prescription medicine administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.
  • Injection into the eye with EYLEA can result in an infection in the eye and retinal detachment (separation of retina from back of the eye). Inflammation in the eye has been reported with the use of EYLEA.
  • In some patients, injections with EYLEA may cause a temporary increase in eye pressure within 1 hour of the injection. Sustained increases in eye pressure have been reported with repeated injections, and your doctor may monitor this after each injection.
  • There is a potential risk of serious and sometimes fatal side effects related to blood clots, leading to heart attack or stroke in patients receiving EYLEA.
  • Serious side effects related to the injection procedure with EYLEA are rare but can occur including infection inside the eye and retinal detachment.
  • The most common side effects reported in patients receiving EYLEA are increased redness in the eye, eye pain, cataract, vitreous (gel-like substance) detachment, moving spots in the field of vision, and increased pressure in the eye.
  • It is important that you contact your doctor right away if you think you might be experiencing any side effects, including eye pain or redness, light sensitivity, or blurring of vision, after an injection.
  • EYLEA is for prescription use only. For additional safety information, please talk to your doctor and see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATIONS

EYLEA® (aflibercept) Injection is a prescription medicine approved for the treatment of patients with Wet Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR) in patients with DME.

Please see the full Prescribing Information for EYLEA.

The information contained herein is provided for general educational purposes. If you have any questions, talk to your doctor.

For U.S. Residents Only

EYLEA AND EYLEA4U are registered trademarks of Regeneron Pharmaceuticals, Inc.

© 2019, Regeneron Pharmaceuticals, Inc. All rights reserved.
777 Old Saw Mill River Road,
Tarrytown, NY 10591

03/2019
US-LEA-14281b(1) US-LEA-14281b(1)

 

Searching with Lea

Close
MENU